MEI Pharma Inc (MEIP)
2.81
+0.01
(+0.36%)
USD |
NASDAQ |
Nov 21, 16:00
2.81
0.00 (0.00%)
Pre-Market: 20:00
MEI Pharma Enterprise Value: -8.182M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -8.182M |
| November 20, 2024 | -8.249M |
| November 19, 2024 | -7.849M |
| November 18, 2024 | -7.749M |
| November 15, 2024 | -7.449M |
| November 14, 2024 | -6.850M |
| November 13, 2024 | -6.716M |
| November 12, 2024 | -5.984M |
| November 11, 2024 | -6.050M |
| November 08, 2024 | -6.650M |
| November 07, 2024 | -6.716M |
| November 06, 2024 | -6.650M |
| November 05, 2024 | -6.650M |
| November 04, 2024 | -6.516M |
| November 01, 2024 | -6.450M |
| October 31, 2024 | -6.25M |
| October 30, 2024 | -6.183M |
| October 29, 2024 | -5.784M |
| October 28, 2024 | -6.35M |
| October 25, 2024 | -8.715M |
| October 24, 2024 | -8.682M |
| October 23, 2024 | -8.649M |
| October 22, 2024 | -8.582M |
| October 21, 2024 | -8.649M |
| October 18, 2024 | -8.449M |
| Date | Value |
|---|---|
| October 17, 2024 | -8.582M |
| October 16, 2024 | -8.449M |
| October 15, 2024 | -8.848M |
| October 14, 2024 | -9.115M |
| October 11, 2024 | -8.915M |
| October 10, 2024 | -8.915M |
| October 09, 2024 | -9.048M |
| October 08, 2024 | -8.848M |
| October 07, 2024 | -8.449M |
| October 04, 2024 | -8.182M |
| October 03, 2024 | -8.582M |
| October 02, 2024 | -8.582M |
| October 01, 2024 | -8.249M |
| September 30, 2024 | -7.916M |
| September 27, 2024 | -19.02M |
| September 26, 2024 | -19.02M |
| September 25, 2024 | -19.29M |
| September 24, 2024 | -18.69M |
| September 23, 2024 | -18.82M |
| September 20, 2024 | -18.49M |
| September 19, 2024 | -17.42M |
| September 18, 2024 | -18.09M |
| September 17, 2024 | -18.36M |
| September 16, 2024 | -18.02M |
| September 13, 2024 | -18.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-114.34M
Minimum
Mar 28 2022
362.99M
Maximum
Jun 23 2020
44.72M
Average
-15.06M
Median
Enterprise Value Benchmarks
| Avid Bioservices Inc | 901.98M |
| Evoke Pharma Inc | 0.348M |
| Revance Therapeutics Inc | 649.94M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.007M |
| Total Expenses (Quarterly) | 8.352M |
| EPS Diluted (Quarterly) | -1.20 |
| Earnings Yield | -248.8% |
| Operating Earnings Yield | 196.2% |
| Normalized Earnings Yield | 217.52 |